Last reviewed · How we verify
Astragalus Membranaceus
At a glance
| Generic name | Astragalus Membranaceus |
|---|---|
| Also known as | Astragalus propinquus |
| Sponsor | China Medical University Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV. (NA)
- The Treatment of Sepsis Induced Myocardial Dysfunction With Yiqilishui Formula (PHASE2)
- Study on the Mechanism of Pei Tu Ning Feng Tang in Alleviating Tourette Syndrome Via Functional Near-Infrared Spectroscopy (fNIRS) and the DA-MAPK-BDNF Pathway (NA)
- Chinese Adaptive Randomised Pneumonia Trial With Respiratory Failure (PHASE4)
- Effect of JointIQ on Joint Discomfort in Healthy Subjects (NA)
- Clinical Outcomes of Treatment With Immunomodulator Plus Cancer Therapies for Patients With Colorectal Cancer
- A Study on the Improvement of Postoperative Symptoms and Survival Benefits of Modified Bufei Decoction in Elderly Patients With Lung Cancer Undergoing Radical Surgery (NA)
- A Clinical Trial of Longqi Jiangzhi Decoction Against Non-alcoholic Fatty Liver Disease (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Astragalus Membranaceus CI brief — competitive landscape report
- Astragalus Membranaceus updates RSS · CI watch RSS
- China Medical University Hospital portfolio CI